logo

For the Inventor, By the Inventor

Tatebayashi, Japan

Yutaka Kawashima

This inventor holds 13 USPTO granted patents, plus 2 CIPO patents. Top assignees: Taisho Pharmaceutical Co., Ltd., Nippon Suisan Kaisha, Ltd.. Active years: 1989-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yutaka Kawashima. Retrieved from https://idiyas.com/inventor/yutaka-kawashima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 86(Granted Patents)


Location History:

  • Tatebayashi, JP (1989 - 1995)
  • Gunma, JP (1995 - 1996)
  • Tokyo, JP (1995 - 1999)

Company Filing History:

goldMedal13 out of 314 
 
Taisho Pharmaceutical Co., Ltd.
 patents
silverMedal2 out of 123 
 
Nippon Suisan Kaisha, Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1989-1999

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 5990151 - Optically active substituted phenylalkylamine derivatives (1999-11-23),
2. 5672712 - Thiazoline derivatives (1997-09-30),
3. 5502202 - Aminoalkylthiazole derivative (1996-03-26),
4. 5496829 - Use of 2-nitroxyethyl (+)apovincaminate (1996-03-05),
5. 5495046 - Alkoxyphenylalkylamine derivatives (1996-02-27),
6. 5478945 - Thiazoline derivatives (1995-12-26),
7. 5475130 - Anilide derivative (1995-12-12),
8. 5416212 - Anilide derivatives (1995-05-16),
9. 5189211 - Sulfonamide derivatives (1993-02-23),
10. 5116995 - Carbazole compounds (1992-05-26),
11. 5028716 - 3,5-diamino-1,2,4-triazole derivatives (1991-07-02),
12. 4952689 - 3-(substituted propylidene)-2-azetidinone derivates for blood platelet (1990-08-28),
13. 4803266 - 3-Oxoalkylidene-2-azetidinone derivatives (1989-02-07),

Title: The Innovative Mind of Yutaka Kawashima

Introduction:

Yutaka Kawashima, an accomplished inventor based in Tatebayashi, Japan, has made significant contributions to the world of pharmaceuticals and bioactive compounds. With a prolific portfolio of 13 patents, his work continues to influence the development of new therapeutic agents.

Latest Patents:

Among Kawashima's recent innovations are the "Optically Active Substituted Phenylalkylamine Derivatives" and "Thiazoline Derivatives". These patents showcase his dedication to advancing scientific knowledge and improving medical treatments through innovative chemical structures.

Career Highlights:

Kawashima's career has been marked by his tenure at notable companies such as Taisho Pharmaceutical Co., Ltd. and Nippon Suisan Kaisha, Ltd. His expertise in the field has not only led to numerous patents but has also positioned him as a valuable asset in the pharmaceutical industry.

Collaborations:

Throughout his career, Yutaka Kawashima has worked alongside esteemed colleagues, including Katsuo Hatayama and Masakazu Sato. These collaborations have fostered a creative environment where innovative ideas could flourish, ultimately leading to the development of groundbreaking inventions.

Conclusion:

Yutaka Kawashima's contributions to the field of pharmaceuticals are significant, with his 13 patents highlighting his inventive spirit and commitment to scientific advancement. His collaborations and work at respected companies demonstrate a career dedicated to improving health outcomes for society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…